Dexibuprofen

Spécifications

51146-56-6Numéro CAS

610-620-9Numéro CE

(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acidNom IUPAC

C13H18O2Formule chimique

206.28 g/molMasse molaire

DEXIBUPROFEN; 51146-56-6; Dexibuprofene; Dexibuprofeno; Seractil; d-Ibuproten; (+)-(S)-p-Isobutylhydratropic acid; Dexibuprofenum; s-ibuprofen; (2S)-2-(4-isobutylphenyl)propanoic acid; (2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid; DTXSID9048724; (+)-Ibuprofen; NSC-759814; 671DKG7P5S; (S)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid; DTXCID6028650; CHEBI:43415; Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (S)-; (2S)-2-(4-(2-methylpropyl)phenyl)propanoic acid; RefChem:585862; M01AE14; (S)-(+)-Ibuprofen; S(+)-Ibuprofen; (S)-2-(4-Isobutylphenyl)propanoic acid; (S)-(+)-2-(4-Isobutylphenyl)propionic acid; S-(+)-ibuprofen; MFCD00069289; Dexibuprofen (free acid); (S)-(+)-4-Isobutyl-alpha-methylphenylacetic acid; CHEMBL175; (S)-2-(4-Isobutylphenyl)propionic acid; NCGC00016861-05; (S)-2-(4-isobutyl-phenyl)-propionic acid; CAS-51146-56-6; S-(+)-2-(4-Isobutylphenyl)propionic acid; (s)-(+)-4-isobutyl-a-methylphenylacetic acid; SMR000326688; (+)-(S)-Ibuprofen; Dexibuprofene [INN-French]; Dexibuprofenum [INN-Latin]; UNII-671DKG7P5S; Dexibuprofeno [INN-Spanish]; Atriscal; Dolomin; DexOptifen; d-Ibuprofen; Maxibufen Syr; Dexibuprofen [USAN:INN:BAN]; Maxibufen ER; ibuprofen-(S); (+)-Ibuprophen; 51146-56-6 (free acid); (s)(+)ibuprofen; S (+) Ibuprofen; (s)(+) ibuprofen; (S)-2-(p-Isobutylphenyl)propionic acid; (S)-(-)-Ibuprofen; Lopac-I-106; Prestwick0_000907; Prestwick1_000907; Prestwick2_000907; Prestwick3_000907; Lopac-I-4883; Dexibuprofen (USAN/INN); DEXIBUPROFEN [INN]; DEXIBUPROFEN [USAN]; Lopac0_000654; SCHEMBL43531; BSPBio_000754; DEXIBUPROFEN [MART.]; MLS001066327; MLS001335879; MLS001335880; DEXIBUPROFEN [WHO-DD]; SPBio_002953; BPBio1_000830; orb1224869; orb1310605; SCHEMBL30091137; (S)-(+)-Ibuprofen (Standard); HMS1570F16; HMS2097F16; HMS2231C07; HMS3262C09; HMS3714F16; HY-78131AR; Pharmakon1600-01502363; Tox21_113141; Tox21_500654; BDBM50169047; EBC-04181; HY-78131A; NSC759814; AKOS015890528; AKOS015994628; CCG-204740; CS-1393; DB09213; FI24528; HS-0088; LP00654; MSK156869-100M; NSC 759814; SDCCGSBI-0050633.P002; NCGC00015529-01; NCGC00015529-02; NCGC00015529-03; NCGC00015529-11; NCGC00016861-01; NCGC00016861-02; NCGC00016861-03; NCGC00016861-06; NCGC00016861-13; NCGC00094017-01; NCGC00094017-02; NCGC00094017-04; NCGC00261339-01; SY046826; UNM-0000306099; AB00513957; EU-0100654; I-106; I0549; NS00098758; T0448; (S)-(+)-Ibuprofen, ReagentPlus(R), 99%; (s)-(+)-2-(4-isobutylphenyl) propionic acid; D03715; EN300-180104; O10202; AB00513957_07; F079519; Q420051; SR-01000075945; SR-01000761395; (2S)-2-[4-(2-Methylpropyl)phenyl]propionic acid; SR-01000075945-1; SR-01000761395-2; (S)-(+)-Ibuprofen Solution in Methanol, 100ug/mL; BRD-K14965640-001-03-3; BRD-K14965640-001-12-4; (+)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid; Z1508914616; (alphaS)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid; benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (alphaS)-; Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-,(alphaS)-; BENZENEACETIC ACID, .ALPHA.-METHYL-4-(2-METHYLPROPYL)-, (S)-; Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (alphaS)- (9CI)Synonymes